期刊
LEUKEMIA & LYMPHOMA
卷 48, 期 10, 页码 2032-2041出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428190701593644
关键词
multiple myeloma; mesenchymal stem cells; osteoblasts; bone lesions
Osteolytic bone lesions are common in patients with multiple myeloma ( MM), a clonal plasma cell disorder, and result from increased osteoclastic bone resorption and decreased osteoblastic bone formation. Because mesenchymal stem cells ( MSCs) are committed towards cells of the osteoblast lineage, we compared the in vitro characteristics of MSCs from the bone marrow of 18 MM patients ( MM-MSCs) and eight normal donors ( ND-MSCs). MM-MSCs displayed deficient growth that could be explained in part by the reduced expression of several growth factor receptors on the surface of MM-MSCs compared with ND-MSCs. Receptor downregulation was observed on RT-PCR analysis. A major finding was an approximately fivefold higher expression of osteoblast inhibitor DKK1 at transcript and protein levels in MM-MSCs than ND-MSCs. These data suggest that defective osteoblast function in patients with advanced MM may be related not only to factors released by tumor myeloma cells but also to MSC abnormalities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据